Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Allergic rhinitis (AR) is a growing public health, medical and economic problem worldwide.
The current review describes the major discoveries related to AR during the past 2 years …

Mast cells have crucial roles in allergic and other inflammatory diseases. Preclinical
approaches provide circumstantial evidence for mast cell involvement in many diseases, but …

Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled
allergens and is one of the most common chronic conditions globally. AR often co-occurs …

Allergen immunotherapy (AIT) is the sole disease-modifying treatment for allergic rhinitis; it
prevents rhinitis from progressing to asthma and lowers medication use. AIT against mites …

Allergic rhinitis in childhood has been often missed, mistreated and misunderstood. It has
significant comorbidities, adverse effects upon quality of life and educational performance …

Different drugs used to treat asthma, such as beta 2 agonists and inhaled steroids, may
promote a higher risk of caries, dental erosion, periodontal disease and oral candidiasis …

Introduction The numerous links between allergic rhinitis and asthma have been extensively
explored in the last two decades, gaining great concern within the scientific community …

The aim of this study was to evaluate the efficacy of mepolizumab in patients affected by
chronic rhinosinusitis with nasal polyps (CRSwNP) in real-life. A single-center retrospective …

MASK‐air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled
large observational implementation studies in over 58,000 people with allergic rhinitis …